Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease

Brain Research

Volumn 1116, Issue 1, 2006, Pages 177-186

  Cannon, Jason R ^a,b   Keep, Richard F ^a,b   Schallert, Timothy ^a,c   Hua, Ya ^a   Richardson, Rudy J ^a,b   Xi, Guohua ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

6 hydroxydopamine; Parkinson's; Protease activated receptor; Protease activated receptor 1; Protease activated receptor 4; Thrombin preconditioning

Indexed keywords

OXIDOPAMINE; PEPTIDE DERIVATIVE; PROTEASE ACTIVATED RECEPTOR 1 AGONIST; PROTEASE ACTIVATED RECEPTOR 1 ANTAGONIST; PROTEASE ACTIVATED RECEPTOR 4 AGONIST; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; COGNITION; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FOREBRAIN; FORELIMB; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; VIBRISSA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; BIOTRANSFORMATION; CATECHOLAMINES; FORELIMB; HOMOVANILLIC ACID; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; SYMPATHOLYTICS; THROMBIN; VIBRISSAE;

EID: 33749261420     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.07.094     Document Type: Article

References (58)

1. Andrade-Gordon P., Maryanoff B.E., Derian C.K., Zhang H.C., Addo M.F., Darrow A.L., Eckardt A.J., Hoekstra W.J., McComsey D.F., Oksenberg D., Reynolds E.E., Santulli R.J., Scarborough R.M., Smith C.E., and White K.B. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc. Natl. Acad Sci. U. S. A. 96 (1999) 12257-12262
2. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., and Becker G. Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 79 (2001) 225-236
3. Cannon J.R., Keep R.F., Hua Y., Richardson R.J., Schallert T., and Xi G. Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model. Neurosci. Lett. 373 (2005) 189-194
4. Carreno-Muller E., Herrera A.J., de Pablos R.M., Tomas-Camardiel M., Venero J.L., Cano J., and Machado A. Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. J. Neurochem. 84 (2003) 1201-1214
5. Choi S.H., Joe E.H., Kim S.U., and Jin B.K. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J. Neurosci. 23 (2003) 5877-5886
6. Choi S.H., Lee da Y., Ryu J.K., Kim J., Joe E.H., and Jin B.K. Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expression of death-related proteins. Neurobiol. Dis. 14 (2003) 181-193
7. Choi S.H., Lee da Y., Kim S.U., and Jin B.K. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J. Neurosci. 25 (2005) 4082-4090
8. Coughlin S.R. Protease-activated receptors start a family. Proc. Natl. Acad Sci. U. S. A. 91 (1994) 9200-9202
9. Dery O., Corvera C.U., Steinhoff M., and Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274 (1998) C1429-C1452
10. Faruqi T.R., Weiss E.J., Shapiro M.J., Huang W., and Coughlin S.R. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J. Biol. Chem. 275 (2000) 19728-19734
11. Hald A., and Lotharius J. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?. Exp. Neurol. 193 (2005) 279-290
12. Hall S., Rutledge J.N., and Schallert T. MRI, brain iron and experimental Parkinson's disease. J. Neurol. Sci. 113 (1992) 198-208
13. Hamill C.E., Caudle W.M., Richardson J.R., Miller G.W., and Traynelis S.F. Role for protease-activated receptor 1 (PAR1) in MPTP-induced dopaminergic neurotoxicity. Abstract Viewer/Itinerary Planner (2004), Society for Neuroscience, Washington, DC Program No. 562.6, Online
14. Hasan A.A., Amenta S., and Schmaier A.H. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation. Circulation 94 (1996) 517-528
15. Hasan A.A., Warnock M., Nieman M., Srikanth S., Mahdi F., Krishnan R., Tulinsky A., and Schmaier A.H. Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H183-H193
16. Hua Y., Keep R.F., Hoff J.T., and Xi G. Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J. Cereb. Blood Flow Metab. 23 (2003) 1448-1454
17. Hua Y., Wu J., Keep R.F., Hoff J.T., and Xi G. Thrombin exacerbates brain edema in focal cerebral ischemia. Acta Neurochir., Suppl. 86 (2003) 163-166
18. Hua Y., Schallert T., Keep R.F., Wu J., Hoff J.T., and Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33 (2002) 2478-2484
19. Ishida Y., Nagai A., Kobayashi S., and Kim S.U. Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J. Neuropathol. Exp. Neurol. 65 (2006) 66-77
20. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl. 3 (2003) S26-S36 (discussion S36-28)
21. Jiang Y., Wu J., Hua Y., Keep R.F., Xiang J., Hoff J.T., and Xi G. Thrombin-receptor activation and thrombin-induced brain tolerance. J. Cereb. Blood Flow Metab. 22 (2002) 404-410
22. Junge C.E., Lee C.J., Hubbard K.B., Zhang Z., Olson J.J., Hepler J.R., Brat D.J., and Traynelis S.F. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp. Neurol. 188 (2004) 94-103
23. Junn E., and Mouradian M.M. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J. Neurochem. 78 (2001) 374-383
24. Kahn M.L., Zheng Y.W., Huang W., Bigornia V., Zeng D., Moff S., Farese Jr. R.V., Tam C., and Coughlin S.R. A dual thrombin receptor system for platelet activation. Nature 394 (1998) 690-694
25. Lee K.R., Betz A.L., Kim S., Keep R.F., and Hoff J.T. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir. (Wien) 138 (1996) 396-400 (discussion 400-391)
26. Lee K.R., Colon G.P., Betz A.L., Keep R.F., Kim S., and Hoff J.T. Edema from intracerebral hemorrhage: the role of thrombin. J. Neurosurg. 84 (1996) 91-96
27. Lee K.R., Betz A.L., Keep R.F., Chenevert T.L., Kim S., and Hoff J.T. Intracerebral infusion of thrombin as a cause of brain edema. J. Neurosurg. 83 (1995) 1045-1050
28. Lee D.Y., Oh Y.J., and Jin B.K. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways. Glia 51 (2005) 98-110
29. Marinissen M.J., Servitja J.M., Offermanns S., Simon M.I., and Gutkind J.S. Thrombin protease-activated receptor-1 signals through Gq- and G13-initiated MAPK cascades regulating c-Jun expression to induce cell transformation. J. Biol. Chem. 278 (2003) 46814-46825
30. Masada T., Xi G., Hua Y., and Keep R.F. The effects of thrombin preconditioning on focal cerebral ischemia in rats. Brain Res. 867 (2000) 173-179
31. Niclou S.P., Suidan H.S., Pavlik A., Vejsada R., and Monard D. Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur. J. Neurosci. 10 (1998) 1590-1607
32. Olson E.E., Lyuboslavsky P., Traynelis S.F., and McKeon R.J. PAR-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia/ischemia. J. Cereb. Blood Flow Metab. 24 (2004) 964-971
33. Orr C.F., Rowe D.B., and Halliday G.M. An inflammatory review of Parkinson's disease. Prog. Neurobiol. 68 (2002) 325-340
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
35. Peng J., Mao X.O., Stevenson F.F., Hsu M., and Andersen J.K. The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J. Biol. Chem. 279 (2004) 32626-32632
36. Pompili E., Nori S.L., Geloso M.C., Guadagni E., Corvino V., Michetti F., and Fumagalli L. Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus. Brain Res. Mol. Brain Res. 122 (2004) 93-98
37. Rohatgi T., Sedehizade F., Sabel B.A., and Reiser G. Protease-activated receptor subtype expression in developing eye and adult retina of the rat after optic nerve crush. J. Neurosci. Res. 73 (2003) 246-254
38. Rohatgi T., Henrich-Noack P., Sedehizade F., Goertler M., Wallesch C.W., Reymann K.G., and Reiser G. Transient focal ischemia in rat brain differentially regulates mRNA expression of protease-activated receptors 1 to 4. J. Neurosci. Res. 75 (2004) 273-279
39. Sabri A., Short J., Guo J., and Steinberg S.F. Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ. Res. 91 (2002) 532-539
40. Schallert T., and Wilcox R.E. Neurotransmitter-selective brain lesions. In: Boulton A.A., and Bakers G.B. (Eds). Neuromethods, 1 (1985), Humana Press, Clifton 343-387
41. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
42. Shao J., Xi G., Hua Y., Schallert T., and Felt B. Intracerebral hemorrhage in the iron-deficient rat. Stroke 36 (2005) 660-664
43. Striggow F., Riek-Burchardt M., Kiesel A., Schmidt W., Henrich-Noack P., Breder J., Krug M., Reymann K.G., and Reiser G. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14 (2001) 595-608
44. Suo Z., Wu M., Ameenuddin S., Anderson H.E., Zoloty J.E., Citron B.A., Andrade-Gordon P., and Festoff B.W. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem. 80 (2002) 655-666
45. Suo Z., Wu M., Citron B.A., Gao C., and Festoff B.W. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J. Biol. Chem. 278 (2003) 31177-31183
46. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., and Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J. Neurosci. 21 (2001) 4427-4435
47. Ugarte S.D., Lin E., Klann E., Zigmond M.J., and Perez R.G. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J. Neurosci. Res. 73 (2003) 105-112
48. Vaughan P.J., Pike C.J., Cotman C.W., and Cunningham D.D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15 (1995) 5389-5401
49. Wang H., and Reiser G. Thrombin signaling in the brain: the role of protease-activated receptors. Biol. Chem. 384 (2003) 193-202
50. Wang H., Ubl J.J., and Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37 (2002) 53-63
51. Wang H., Ubl J.J., Stricker R., and Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am. J. Physiol.: Cell Physiol. 283 (2002) C1351-C1364
52. Weinstein J.R., Gold S.J., Cunningham D.D., and Gall C.M. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15 (1995) 2906-2919
53. Woodlee M.T., and Schallert T. The interplay between behavior and neurodegeneration in rat models of Parkinson's disease and stroke. Restor. Neurol. Neurosci. 22 (2004) 153-161
54. Xi G., Keep R.F., Hua Y., Xiang J., and Hoff J.T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30 (1999) 1247-1255
55. Xi G., Hua Y., Keep R.F., Duong H.K., and Hoff J.T. Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance. Brain Res. 895 (2001) 153-159
56. Xi G., Reiser G., and Keep R.F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?. J. Neurochem. 84 (2003) 3-9
57. Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A., Gilbert T., Davie E.W., and Foster D.C. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad Sci. U. S. A. 95 (1998) 6642-6646
58. Zhang L., Schallert T., Zhang Z.G., Jiang Q., Arniego P., Li Q., Lu M., and Chopp M. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Methods 117 (2002) 207-214